Protalix BioTherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.About PLX
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11.
CEODror Bashan
CEODror Bashan
Employees213
Employees213
HeadquartersHackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded1993
Founded1993
Employees213
Employees213
PLX Key Statistics
Market cap141.94M
Market cap141.94M
Price-Earnings ratio25.76
Price-Earnings ratio25.76
Dividend yield—
Dividend yield—
Average volume676.06K
Average volume676.06K
High today$1.80
High today$1.80
Low today$1.72
Low today$1.72
Open price$1.78
Open price$1.78
Volume770.50K
Volume770.50K
52 Week high$3.10
52 Week high$3.10
52 Week low$1.32
52 Week low$1.32
Stock Snapshot
With a market cap of 141.94M, Protalix BioTherapeutics(PLX) trades at $1.78. The stock has a price-to-earnings ratio of 25.76.
On 2026-01-07, Protalix BioTherapeutics(PLX) stock traded between a low of $1.72 and a high of $1.80. Shares are currently priced at $1.78, which is +3.5% above the low and -1.1% below the high.
Protalix BioTherapeutics(PLX) shares are trading with a volume of 770.5K, against a daily average of 676.06K.
In the last year, Protalix BioTherapeutics(PLX) shares hit a 52-week high of $3.10 and a 52-week low of $1.32.
In the last year, Protalix BioTherapeutics(PLX) shares hit a 52-week high of $3.10 and a 52-week low of $1.32.
People also own
Based on the portfolios of people who own PLX. This list is generated using Robinhood data, and it’s not a recommendation.